Format MyFHC (4)

B7-B20: OECD - Side-event

High-Level Roundtable on Health and Life Sciences Competitiveness

Le 21 janvier 2026, 9h.
OECD Headquarters, Paris (Participation upon invitation.)

A l'occasion de la présidence française du G7 en 2026 et dans le cadre du French Healthcare Business Forum, cette table ronde réunit les décideurs du G7 et de l'OCDE afin d'étudier les modalités d'intégration de politiques sanitaires et économiques au bénéfice de la société, de la croissance et la compétitivité des économies.

Untitled design (8)

Part 1: The Economic Case for Investments in Life Sciences and Health Competitiveness

This structured discussion will examine how strategic investment in life sciences and health systems strengthens countries’ economic competitiveness, growth potential, as well as economic security across R&D, clinical trials, manufacturing, etc.

Part 2: Cross-Cutting Policy Approaches

This session will explore how countries can develop cross-cutting policy frameworks that bridge health, economic, and industrial agendas to accelerate life sciences innovation and strengthen competitiveness.

Panellists will examine how coordinated approaches can unlock greater value from health innovation. The discussions will help identifying concrete solutions and actionable recommendations.